2,705
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Systemic Lupus Erythematosus and the Eye

, &

REFERENCES

  • Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384:1878–1888.
  • Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110–2121.
  • Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med. 2017;23:615–635.
  • Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18:135–149.
  • Silpa-Archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100:135–141.
  • Shoughy SS, Tabbara KF. Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol. 2016;30:117–121.
  • Preble JM, Silpa-Archa S, Foster CS. Ocular involvement in systemic lupus erythematosus. Curr Opin Ophthalmol. 2015;26:540–545.
  • Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898.
  • Davies JB, Rao PK. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2008;19:512–518.
  • Read RW. Clinical mini-review: systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2004;12:87–99.
  • Arevalo JF, Lowder CY, Muci-Mendoza R. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2002;13:404–410.
  • Shein J, Shukla D, Reddy S, Yannuzzi LA, Cunningham ET Jr. Macular infarction as a presenting sign of systemic lupus erythematosus. Retin Cases Brief Rep. 2008;2:55–60.
  • Cunningham ET Jr, Alfred PR, Irvine AR. Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology. 1996;103:2081–2090.
  • Hasanreisoglu M, Gulpinar Ikiz GD, Kucuk H, Varan O, Ozdek S. Acute lupus choroidopathy: multimodal imaging and differential diagnosis from central serous chorioretinopathy. Int Ophthalmol. 2018;38:369–374.
  • Nemiroff J, Phasukkijwatana N, Vaclavik V, Nagiel A, Holz ER, Sarraf D. The spectrum of amalric triangular choroidal infarction. Retin Cases Brief Rep. 2017;11:S113–S120.
  • Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000;11:478–483.
  • Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye (Lond). 2017;31:828–845.
  • Dammacco R, Procaccio P, Racanelli V, Vacca A, Dammacco F. Ocular involvement in systemic lupus erythematosus: the experience of two tertiary referral centers. Ocul Immunol Inflamm. 2018;26:1154–1165. doi: 10.1080/09273948.2018.1501495.
  • Zhang J, Chen Y, Yu Z, Liu L. Bilateral hemorrhagic retinopathy with roth spots in pediatric-onset systemic lupus erythematosus and associated thrombocytopenia: a case report and review of literature. Ocul Immunol Inflamm. 2017; 26:1150–1153. doi:10.1080/09273948.2017.1370652.
  • Lee KR, Peng LY, Iqbal TB, Subrayan V. Role of angiography in systemic lupus erythematosus-induced choroiditis. Ocul Immunol Inflamm. 2017;26:1146–1149. doi:10.1080/09273948.2017.1298821.
  • Cunningham ET Jr, Acharya N, Kempen JH, Design ZM. Interpretation of clinic-based studies in uveitis. Ocul Immunol Inflamm. 2015;23:267–270.
  • Duane TD, Osher RH. Green WR. White-centered hemorrhages: their significance. Ophthalmology. 1980; 87:66–69.
  • Herbort CP, Mantovani A, Papadia M. Use of indocyanine green angiography in uveitis. Int Ophthalmol Clin. 2012;52:13–31.
  • Gallagher K, Viswanathan A, Okhravi N. Association of systemic lupus erythematosus with uveitis. JAMA Ophthalmol. 2015;133:1190–1193.
  • Jabs DA, Busingye J. Approach to the diagnosis of the uveitides. Am J Ophthalmol. 2013;156:228–236.
  • Rosenbaum JT, Wernick R. The utility of routine screening of patients with uveitis for systemic lupus erythematosus or tuberculosis. A Bayesian Analysis. Arch Ophthalmol. Sep 1990;108(9):1291–1293.
  • Cunningham ET Jr, Smith JR, Tugal-Tutkun I, Rothova A, Zierhut M. Uveitis in children and adolescents. Ocul Immunol Inflamm. 2016;24:365–371.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.